WHO prequalifies first biosimilar medicine to increase access to cancer treatment

The World Health Organization (WHO) has prequalified its first biosimilar medicine, trastuzumab in a move to enable women with breast cancer all over the world get affordable and accessible treatment.

Editor

Latest news today on Tedros Adhanom Ghebreyesus

WHO prequalifies first biosimilar medicine to increase access to cancer treatment

One person commits suicide every 40 seconds, says WHO

WHO preaches abstinence from tobacco, harps on wellness

How baked, fried foods raise death risk

WHO calls for improved access to primary healthcare

WHO launches strategy to fight 'inevitable' flu pandemics

Nigeria, others spending more on health but people still paying too much form their pockets, says WHO

Travails of Africans working with UN agencies persist

Health benefits of meeting climate change goals

Global fight against malaria has stalled, WHO warns

'Just say no' to drug legalisation: WHO chief

Reducing burden of heart disease in Nigeria

More Africans smoke, die of tobacco-induced sicknesses, says WHO

WHO chief heads to DR Congo over latest Ebola outbreak

Seven million people die yearly from contaminated air, says WHO

Towards healthier, safer environment

Preventing premature deaths with improved health funding

Army to recruit 28,000 additional soldiers to combat insecurity

NUJ condemns rising political violence ahead of Osun election

Federal lawmaker prays for peace, abducted pupils during Umrah

Gov. Otu inaugurates environmental task force to enforce sanitation laws

The News You Need, Delivered To You.